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Abstract: This study was performed to investigate the association of prohibitin with renal 
interstitial fibrosis (RIF) lesion and to explore the association of all-trans retinoic acid (ATRA) 
treatment with prohibitin expression in RIF rats. Rats were divided into three groups: the sham 
operation group (SHO), the model group subjected to unilateral ureteral obstruction (UUO), 
and the model group treated with ATRA (GA). Renal tissues were collected at 14 and  
28 days after surgery, and the relevant indicators were detected. In comparison with the SHO 
group, the RIF index in the UUO group was markedly elevated (p < 0.01), and the RIF index 
in the GA group was alleviated compared with that in the UUO group (p < 0.01). Compared 
with the SHO group, the expression of prohibitin (protein or mRNA) in the UUO group was 
significantly reduced (each p < 0.01). Prohibitin expression in the GA group was markedly 
increased when compared with that in the UUO (p < 0.01). The expression of TGF-β1 (protein 
and mRNA), protein expressions of Col-IV, fibronectin, α-SMA and cleaved Caspase-3, ROS 
generation and cell apoptosis index in the UUO group were markedly higher than those in the 
SHO group (all p < 0.01), and their expressions in the GA group were markedly down-regulated 
compared to those in the UUO group (all p < 0.01, respectively). The protein expression of 
prohibitin was negatively correlated with the RIF index, protein expression of TGF-β1, 
Col-IV, fibronectin, α-SMA or cleaved Caspase-3, ROS generation and the cell apoptosis 
index (each p < 0.01). In conclusion, lower expression of prohibitin is associated with the 
RIF, and ATRA treatment is associated with increased prohibitin, which can prevent the 
progression of RIF. 
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1. Introduction 
Renal interstitial fibrosis (RIF) is the final common pathway leading to chronic kidney diseases and 
end-stage renal disease [1,2], and its effective therapeutic strategy is wanting at present. Unilateral ureteral 
obstruction (UUO) is a well-characterized model of experimental obstructive nephropathy, culminating in 
RIF [3,4]. Currently, investigations have found that the reactive oxidative species (ROS) can contribute to 
the progression of renal disease induced by UUO [5,6]. 
Prohibitin is a ubiquitous protein with a number of different molecular functions [7] and it is mainly 
located on the inner mitochondrial membrane and nuclei [8]. It plays a pivotal role in the processes of 
cell differentiation and apoptosis [9]. The over-expression of prohibitin could protect the mitochondria 
from ROS-induced injury [10]. The abnormal expression of prohibitin might be associated with  
RIF progression. 
All-trans retinoic acid (ATRA), a natural derivative of vitamin A [11], has been shown to have a 
variety of functions, including a role as an antioxidant and regulator of cell differentiation and  
apoptosis [12,13]. Some investigations [14–16] reported that ATRA could play a protective role in some 
renal diseases, but the detailed mechanism was not clear. Interestingly, ATRA treatment can suppress 
the generation of ROS [12], and have an anti-oxidative effect [17]. As mentioned above, we drew up a 
hypothesis that ATRA treatment is associated with the expression of prohibitin. This investigation was 
performed to explore this hypothesis in RIF rats induced by UUO. 
2. Results 
2.1. Renal Morphology 
Light microscopy showed more collagen deposition, fibroblast proliferation and diffused lymphocytes 
filtration in the renal tubulointerstitium of the UUO group when compared with those in the SHO group 
(blue arrowhead in Figure 1), but the lesion degree in the GA group was less serious than that in 
the UUO group (blue arrowhead in Figure 1). The RIF score in the UUO group was significantly 
increased over that in the SHO group, and the RIF index in the GA group was markedly alleviated compared 
with that in the UUO group (all p < 0.01; Figure 1). Int. J. Mol. Sci. 2012, 13                 
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Figure 1. (1) Statistical parameters in three groups. *: p < 0.01 compared with sham 
operation group (SHO), **: p < 0.01 compared with unilateral ureteral obstruction group 
(UUO); (2) Tissue characteristics in three groups. Masson staining for SHO group (A1: 
14-day; A2: 28-day), UUO group (A3: 14-day; A4: 28-day) and model group treated with 
ATRA (GA) (A5: 14-day; A6: 28-day). Representative samples of immunohistochemical 
staining for TGF-β1 (SHO: B1: 14-day, B2: 28-day; UUO: B3: 14-day, B4: 28-day; GA: B5: 
14-day; B6: 28-day), Col-IV (SHO: C1: 14-day, C2: 28-day; UUO: C3: 14-day, C4: 28-day; 
GA: C5: 14-day; C6: 28-day), and fibronectin (SHO: D1: 14-day, D2: 28-day; UUO:  
D3: 14-day; D4: 28-day; GA: D5: 14-day; D6: 28-day) were observed in three groups. 
Magnification × 400. 
%  % 
%  % 
* 
*
*
*
*
*
*
* 
** **
**
** 
** 
** **
**Int. J. Mol. Sci. 2012, 13                 
 
2772
Figure 1. Cont. 
 
SHO  14-day    SHO  28-day      UUO  14-day     UUO  28-day      GA  14-day      GA  28-day 
2.2. Association of ATRA Treatment with TGF-βl, Col-IV, Fibronectin, α-SMA, Prohibitin or Cleaved 
Caspase-3 Protein Expression 
The staining of prohibitin in the SHO group was more significant than that in the UUO group or GA 
group (blue arrowhead in Figure 2). The stainings of TGF-βl, Col-IV, fibronectin, α-SMA and cleaved 
Caspase-3 in the UUO group were much more significant compared with those in the SHO group / GA 
group (blue arrowhead in Figure 1 and 2). Comparison with that in the SHO group, the protein 
expression of prohibitin in the UUO group was significantly weakened, and protein expression of 
prohibitin in the ATRA treatment group was markedly increased over that in the UUO group (p < 0.01; 
Figure 2). The protein expressions of TGF-βl, Col-IV, fibronectin, α-SMA and cleaved Caspase-3 in the 
UUO group were significantly increased when compared with those in the SHO group, and the TGF-βl, 
Col-IV, fibronectin, α-SMA and cleaved Caspase-3 expressions in the GA group were lower than those in 
the UUO group (all p < 0.01; Figure 1 and 2). Protein expression of prohibitin was negatively correlated 
with the RIF index, protein expression of TGF-βl, Col-IV, fibronectin, α-SMA or cleaved Caspase-3  
(r = −0.825, −0.786, − 0.948, −0.817, −0.953, −0.863; each p < 0.01, respectively). Int. J. Mol. Sci. 2012, 13                 
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Figure 2. (1) Statistical parameters for α-SMA, prohibitin, cleaved Caspase-3 and cell apoptosis 
index in three groups. *: p < 0.01 compared with SHO, **: p < 0.01 compared with UUO;  
(2) Tissue characteristics in three groups. Representative samples of immunohistochemical 
staining for α-SMA (SHO: E1: 14-day, E2: 28-day; UUO: E3: 14-day, E4: 28-day; GA:  
E5: 14-day; E6: 28-day), prohibitin (SHO: F1: 14-day, F2: 28-day; UUO: F3: 14-day,  
F4: 28-day; GA: F5: 14-day; F6: 28-day), and cleaved Caspase-3 (SHO: G1: 14-day,  
G2: 28-day; UUO: G3: 14-day, G4: 28-day; GA: G5: 14-day; G6: 28-day) were observed in 
three groups. Cell apoptosis also detected in three groups (SHO: H1: 14-day, H2: 28-day; 
UUO: H3: 14-day, H4: 28-day; GA: H5: 14-day; H6: 28-day). Magnification × 400. 
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Figure 2. Cont. 
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2.3. Association of ATRA Treatment with Cell Apoptosis 
The staining of cell apoptosis of the renal tubulointerstitium was much more significant in the UUO 
group than in the SHO group (blue arrowhead in Figure 2), and the cell apoptosis index in the UUO 
group was significantly increased when compared with that in SHO (p < 0.01; Figure 2). Cell apoptosis 
in the renal tubulointerstitium in the ATRA treatment group was attenuated (blue arrowhead in Figure 2), 
and the apoptosis index in the GA group was significantly reduced over that in the UUO group (p < 0.01; 
Figure 2). Protein expression of prohibitin was negatively correlated with the cell apoptosis index  
(r = −0.886, p < 0.01). 
2.4. Association of ATRA Treatment with ROS Generation, mRNA Expressions of Prohibitin and TGF-βl 
When compared with that in the SHO group, the generation of ROS in the UUO group was markedly 
increased, especially in 28-days (p < 0.01; Figure 3). ROS generation in the GA group was alleviated 
when compared with that of the UUO group (p < 0.01; Figure 3). Protein expression of prohibitin was 
negatively correlated with ROS generation (r = −0.859, p < 0.01). Consistently lower prohibitin mRNA 
expression and higher TGF-βl mRNA expression were shown in the renal tissue of the UUO group when 
compared with that in the SHO group (all p < 0.01; Figure 3). Prohibitin mRNA expression was significantly 
up-regulated and TGF-βl mRNA expression was markedly reduced in the GA group when compared with 
the UUO group (all p < 0.01; Figure 3). Int. J. Mol. Sci. 2012, 13                 
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Figure 3. Statistical parameters for reactive oxidative species (ROS), prohibitin mRNA, and 
TGF-β1 mRNA. *: p < 0.01 compared with SHO, **: p < 0.01 compared with UUO. 
3. Discussion 
Of all the cytokines and growth factors involved, TGF-β1 plays a pivotal role in the processes of renal 
interstitial fibrosis (RIF) [18]. TGF-β1 is known as one of the major mediators that leads to RIF by 
inducing the production of α-SMA and ECM (Col-IV and fibronectin) in the renal 
tubulointerstitium [19–21]. Those indicators were chosen and evaluated in this investigation. 
Prohibitin is an ubiquitous protein and might play a pivotal role in the process of cell apoptosis, and 
ATRA treatment can have an antioxidant effect and regulate the cell apoptosis. In this investigation, the 
ROS generation, the cleaved Caspase-3 and the cell apoptosis index were also evaluated. 
In our study, we found that the expressions of TGF-β1, α-SMA, Col-IV and fibronectin in the UUO  
group were markedly increased when compared to those in the SHO group, especially in 28-days. 
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However, the expression of prohibitin in the UUO group was markedly reduced over that in SHO. Protein 
expression of prohibitin was negatively correlated with the RIF index, protein expression of TGF-βl, 
α-SMA, Col-IV, fibronectin or cleaved Caspase-3, ROS generation or cell apoptosis index. The number 
of apoptotic cells in the UUO group was much more than in the normal control group. The lower 
expression of prohibitin was associated with increased cell apoptosis and RIF lesion. Interestingly, the 
prohibitin mainly located in renal tubular epithelial cells (RTEC) and apoptotic cells, observed by us, was 
mainly contributed by RTEC in our study. We speculated that the mechanism might be as follows: The 
expression of prohibitin in RTEC in the UUO model was reduced. The generation of TGF-βl and ROS 
was increased, which induced the expressions of α-SMA, Col-IV and fibronectin in the renal 
tubulointerstitium and increased the production of cleaved Caspase-3 in RTEC. The cell apoptosis index 
was also up-regulated. The less expression of prohibitin was associated with increased expressions of 
ROS, TGF-βl, α-SMA, Col-IV, fibronectin, cleaved Caspase-3 and the index of cell apoptosis. 
Prohibitin is a highly conserved, ubiquitously expressed protein that participates in diverse processes 
including mitochondrial chaperone, growth and apoptosis [22] and is regarded as an apoptosis-regulating 
protein [23]. Prohibitin has played a protective role in some studies. Theiss et al. [24] reported that the 
elevation of prohibitin in the surface epithelial cells of the colon could reduce the severity of colitis in 
mice, suggesting that prohibitin might represent a novel therapeutic target in inflammatory bowel disease. 
Ko  et al. [22] found that hepatocyte-specific prohibitin deficiency resulted in marked liver injury, 
oxidative stress, and fibrosis with development of hepatocellular carcinoma, suggesting that the prohibitin 
was a tumor suppressor in hepatocytes. Muraguchi et al. [25] performed an investigation into H9C2 
cardiomyocytes, and found that prohibitin might function as a survival factor against hypoxia-induced cell 
death. Liu et al. [10] conducted a study in cardiomyocytes, and their data indicated that prohibitin could 
protect the cardiomyocytes from oxidative stress-induced damage. The results from these studies 
mentioned above drew a consistent conclusion that prohibitin was associated with injury of cells or 
tissues. The results were similar to ours. So, how to regulate the abnormal expression of prohibitin is very 
important; prohibitin might be a potential therapeutic target for regulation of cell apoptosis and prevention 
of cell or tissue injury. However, cell culture using RTEC, etc., and the inhibition of the signalling pathway 
of prohibitin need to be conducted to explore further its detailed mechanism in the progression of RIF. 
In this investigation, we found that ATRA treatment was associated with increased expression  
of prohibitin, attenuation of the lesion of the renal tubulointerstitium and reduction in the expressions of 
TGF-βl, α-SMA, Col-IV, fibronectin, ROS and cleaved Caspase-3. Kishimoto et al. [26] also performed 
an investigation on the association of ATRA treatment with RIF progression in UUO model mice, and 
found that a significant improvement was observed in histological and immunological findings in the 
ATRA treatment group. Their results were similar to ours. 
There was no report investigating whether ATRA treatment was associated with the expression of 
prohibitin in vivo or in vitro. Li et al. [9] showed that prohibitin was localized in the nuclear matrix in 
human neuroblastoma SK-N-SH cells and its distribution was altered due to retinoic acid treatment, but 
they did not explore whether the retinoic acid treatment was associated with prohibitin expression. Int. J. Mol. Sci. 2012, 13                 
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4. Materials and Methods 
4.1. Animal Model 
Wistar male rats (6-week-old) were purchased from the Experimental Animal center of Guangxi 
Medicial University, Nanning, China. The rats were divided into 3 groups: sham operation group (SHO), 
model group subjected to unilateral ureteral obstruction (UUO), model group treated with ATRA (GA); 
n = 40, respectively. The ureter was ligated at approximately 1 cm below the renal hilum with a 3–0 silk 
suture. The abdominal wound was closed, and the rats were returned to the cages. Control rats underwent 
abdominal incision and approximation with no ligation of the ureter [27,28]. The rats in the GA group 
were treated with ATRA (Sigma Co., USA; 15 mg/kg·d) in corn oil once daily by oral gavage, from the 
first day before operation. Rats in the UUO and SHO groups were administered with saline. Twenty rats of 
the three groups were sacrificed 14 and 28 days after surgery respectively, and the renal tissue was 
collected for the determination of histological and molecular biology. 
The Animal Care and Use Committee of Guangxi Medical University approved all protocols. 
4.2. Renal Morphology 
After 10% neutral formaldehyde fixation, the renal tissue was dehydrated through a graded ethanol 
series and embedded in paraffin. Sections were prepared on a microtome and stained with Masson’s 
trichrome staining. Renal morphology was observed by light microscopy, the severity of the renal lesion was 
presented by the RIF index. Blue granular and linear deposits were interpreted as positive areas for 
collagen staining. Semi-quantitative evaluation was performed by computer-assisted image analysis 
(DMR + Q550, Leica Co., Germany). 400-fold original magnifications in ten fields (ignoring the fields 
containing glomerular parts) were measured, selected from coded sections for each rat at random. The 
extent of interstitial fibrosis was scored as: absent (0), involving less than 25% of the area (1), involving 
26 to 50% of the area (2), and involving greater than 50% of the area (3) [29,30]. RIF index was obtained 
by the formula as follow: RIF index = (0 × n0 + 1 × n1 + 2 × n2 + 3 × n3)/(n0 + n1 + n2 + n3) = (0 × n0 +  
1 × n1 + 2 × n2 + 3 × n3)/10; where n0, n1, n2 and n3 were the number of extent of interstitial fibrosis as 
absent, less than 25% of the area, 26 to 50% of the area, and greater than 50% of the area, respectively. 
All the fields were selected from coded sections for each rat at random and the scores obtained by two 
investigators were averaged. 
4.3. Immunohistochemical Analysis of the Protein Expressions of Prohibitin, Transforming Growth 
Factor-β1 (TGF-β1), Collagen-IV (Col-IV), Fibronectin, α-Smooth Muscle Actin (α-SMA) and Cleaved 
Caspase-3 
Kidney tissue fixed with 4% buffered paraformaldehyde was embedded in paraffin, and 4 μm thick 
sections were stained. The positive area was measured using a computer-aided manipulator (DMR + Q550, 
Leica Co., Germany). For immunohistochemical analysis of prohibitin, TGF-β1, Col-IV, fibronectin, 
α-SMA and cleaved Caspase-3, the sections were deparaffinized and washed with PBS. In order to  
retrieve the antigenicity from formalin fixation, the sections were incubated for 10 min in 10 mmol/L 
sodium citrate buffer using a microwave oven. After the incubation, all the sections were treated with 3% Int. J. Mol. Sci. 2012, 13                 
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H2O2 in methanol for 10 min. All sections were then incubated with anti-prohibitin antibody (1:300) 
(Neomarker Lab, Co., USA), anti-TGF-β1 antibody (1:100) (Zhongshan, Co., Beijing, China), 
anti-Col-IV antibody (ready-to-use kit; Bo Shide, Co., Wuhan, China), anti-fibronectin antibody (1:50) 
(Zhongshan, Co., Beijing, China), anti-α-SMA antibody (ready-to-use kit; Shanghai Changdao, Co., Inc., 
China) and anti- cleaved- Caspase-3 antibody (1:200) (Thermo Fisher Scientific, Co., Runcorn, UK), 
respectively. After incubation with second antibody immunoglobulin (Shanghai Changdao, Co., 
Shanghai, China), the sections were stained with diaminobenizidine (Maixin Bio, Co., Fuzhou, China). 
Prohibitin, TGF-βl, Col-IV, fibronectin, α-SMA or cleaved Caspase-3 in renal tissue was measured by 
semi-quantitative evaluation. During evaluation of the interstitial areas, fields containing glomerular parts 
were ignored. All the evaluations were performed by two of the authors blind to the experimental code. 
4.4. Apoptosis Assay 
Cell apoptosis was examined by the TdT mediated dUTP nick end labelling (TUNEL) assay (Roche 
Inc., Basel, Switzerland) as described previously [31,32]. Six slides from each kidney were evaluated for 
percentage of apoptotic cells by using the TUNEL assay. Then 10 watch fields, which did not include the 
glomerular parts, were chosen at random under the microscope for each section. Brown staining of cell 
nuclei was on considered apoptotic cells. Positive brown cells and total cells were counted. The formula 
for the apoptosis index as the indicator of apoptosis was as follows [33,34]: cell apoptosis index = 
positive cells/total cells × 100%. The scores obtained by two investigators were averaged. 
4.5. ROS Measurement 
The cortical material of freshly dissected renal tissues was extracted, washed, weighed and homogenized 
in ice cold 0.9% normal saline solution. The homogenate was centrifuged at 4000 × g for 15 min at 
25 °C and the supernatant was used for the determination [35]. The 500 μL of homogenates were used 
for detection of the ROS generation by the ROS sensitive dye, 2,7-dichlorodihydro-fluorescein diacetate 
(DCF-DA; Invitrogen, Co., USA), as an indicator [36,37]. Sample (50 μg protein) was incubated with 
10 μL of DCF-DA (10 μM) for 3 h at 37 °C. The fluorescent product formed was measured by 
spectrofluorometer at 485/525 nm. Changes in fluorescence were expressed as an arbitrary unit [36]. 
4.6. Real Time Reverse Transcription Polymerase Chain Reaction to Detect Prohibitin/TGF-β1 mRNA 
Expression in Renal Tissue 
Renal tissue was homogenized, and total RNA was extracted with TRIzol (Beijing Tiangen, Co., 
China). Primers were designed according to primer design principles by Primer Premier 5.0. The primers 
for prohibitin, TGF-βl and internal control β-actin were as follows: F 5'-TGGCGTTAGCGGTTACA 
GGAG- 3' and R 5'-GAGGATGCGTAGTGTGATGTTGAC-3' for prohibitin; F 5'-TGAGCACTGA 
AGCGAAAGCC-3' and R 5'-GATTCAAGTCAACTGTGGAGCAAC-3' for TGF-βl; F 5'-GCCCCT 
GAGGAGCACCCTGT-3' and R 5'-ACGCTCGGTCAGGATCTTCA-3' for β-actin. One microgram 
total RNA from the renal tissue of each rat was reverse transcribed into cDNA with an ExScript RT 
reagent kit (Takara Biotechnology, Co., Dalian, China). Prohibitin, TGF-βl and β-actin were amplified 
with SYBR Premix Ex Taq (Beijing Tiangen, Co., China). Gene expression of β-actin was also Int. J. Mol. Sci. 2012, 13                 
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measured in each sample, and was used as an internal control for loading and reverse transcription 
efficiency. The analysis for each sample was performed in triplicate. The average threshold cycle (Ct, 
the cycles of template amplification to the threshold) was worked out as the value of each sample. The 
data of fold of changes was analyzed using 2
−ΔΔCt [38,39]. For example, the ΔΔCt of prohibitin mRNA 
expression in UUO group in 14-day was as follow: ΔΔCtprohibitin,14-day,UUO group = (Ct prohibitin, 14-day, UUO group 
− Ct β-actin, 14-day, UUO group) − (Ct prohibitin, 14-day, SHO group − Ct β-actin, 14-day, SHO group), and the fold of changes of 
prohibitin mRNA expression in the UUO group in 14-days was 2
−ΔΔCtprohibitin, 14-day, UUO group. 
4.7. Statistical Analysis 
The data are shown as mean ± standard deviation. Analysis of covariance and Student-Newman Keuls 
post-tests was performed to determine the differences among groups, and Pearson’s correlation coefficient 
was used to determine the relationships between the indicators. A value of p < 0.05 was considered as a 
significant difference. Statistical analysis was performed using the statistical package for social studies 
SPSS version 13.0 (SPSS, Chicago, IL, USA). 
5. Conclusion 
In conclusion, lower expression of prohibitin is associated with RIF progression, and ATRA treatment 
is associated with increased prohibitin in UUO rats, although the detailed mechanism is not fully 
understood. However, cell culture and further investigations should be conducted to explore the  
detailed mechanism. 
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